STOK Earnings Stoke Therapeutics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–21 of 21
| Q2 2026 | 2026-06-30 | -1.73 | 2026-08-03 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.79 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -0.12 | 2026-03-16 | 10-K |
| Q3 2025 | 2025-09-30 | 0.85 | 2025-11-04 | 10-Q |
| Q2 2026 | 2025-06-30 | 1.50 | 2026-08-03 | 10-Q |
| Q1 2026 | 2025-03-31 | 1.90 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -1.65 | 2026-03-16 | 10-K |
| Q3 2025 | 2024-09-30 | -1.48 | 2025-11-04 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.02 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.57 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | -2.38 | 2025-03-18 | 10-K |
| Q3 2024 | 2023-09-30 | -1.78 | 2024-11-05 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.23 | 2024-08-07 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.53 | 2024-05-06 | 10-Q |
| FY 2023 | 2022-12-31 | -2.60 | 2024-03-25 | 10-K |
| Q3 2023 | 2022-09-30 | -1.95 | 2023-11-07 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.29 | 2023-08-07 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.66 | 2023-05-04 | 10-Q |
| FY 2022 | 2021-12-31 | -2.34 | 2023-03-06 | 10-K |
| Q3 2022 | 2021-09-30 | -1.06 | 2022-11-14 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.06 | 2022-08-08 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.